Motivated by her own experience and a desire to help future breast cancer patients who will face similar challenges, Bev Guzy decided to fund promising breast cancer research and ongoing education at Rush. Read more.
The organization uses charitable concert events to fuel scientific discoveries raising $15,000 for Rush's rare disease efforts since 2013. Read more.
Rush is planning a mobile stroke unit that will bring faster diagnosis and treatment to patients at their homes or wherever they’re in need. Read more.
Amanda (Sprenger) Sarmiento faced a complex and rare case of osteosarcoma. Effective treatments are scarce, but thanks in part to the generosity of Amanda’s family and friends in her honor, one physician at Rush is changing that. Read more.
K. Ranga Rama Krishnan, MB, ChB; Henry P. Russe, MD, Dean, Rush Medical College Senior Vice President, Rush University Medical Center, shares his thoughts on evolving medical education at Rush. Read more.
Researchers at Rush have found a new predictor for kidney disease: suPAR, a common blood protein that shows rising levels years before the condition develops. Read more.
Chris Draft and Jill Feldman both experienced firsthand that people who don't smoke can develop lung cancer. The two are raising funds for lung cancer research and treatment, and to raise awareness for the wide array of cases out there. Read more.
When Richard Abrams, MD, associate program director of Internal Medicine Residency at Rush, was on the brink of his residency training, he asked his father — a Chicago surgeon — who he thought were the best doctors in the city to work with: Stuart Levin, MD, was at the top of the list. Read more.